Health Care Sector

Raydel Australia and Cuba’s CNIC Sign Joint Venture

Raydel Australia PTY LTD and the National Center for Scientific Research (CNIC) have established a joint venture to commercialize the use of Policosanol (PPG) and Abexol medicines.

The joint venture expands the international presence of the Biotechnological and Pharmaceutical Industries Group (BioCubaFarma), enhancing the international prestige of the island’s biopharmaceutical sector.

Dr. Kyung-Hyun Cho, head of RAYDEL Research Institute and Dr. Yoshinari Uehara, M.D. Ph.D., of the Department of Cardiology, Fukuoka University Hospital took part in the event at the Cuban Embassy in Australia.

The Raydel Group Australia

The Raydel Group has branch offices in Korea, Japan and China. It is a pharmaceutical manufacturing company offering high quality, naturally-sourced products that enhance life quality and provide health benefits to patients.

Advertisement. Scroll to continue reading.

CNIC is a part of the BioCubaFarma Group

Founded in 1965, the CNIC is a part of the BioCubaFarma business group. The company is dedicated to research, production and pharmaceutical marketing. The CNIC is the first multidisciplinary scientific center in Cuba.

The CNIC and Raydel’s joint venture endorses a long tradition of collaboration in Cuban biopharmaceuticals. It also promotes the reputation and usage of the two drugs in the international marketplace.

Julio Alfonso, president of Dalmer Laboratories S.A., for the CNIC, and Byong Ku Lee, general director of Raydel, signed the agreement. The joint venture confirms the will of both companies to continue developing the strategic alliance.

Clinical trials in Cuba confirmed the effectiveness of PPG as a potential adjuvant drug to control pre-hypertension and hypertension in patients with low cardiovascular risk. The results showed a significant decrease in maximum and minimum values after 12 weeks of testing.

Advertisement. Scroll to continue reading.

Abexol is used for the relief of mild osteoarthritis, enhances healthy joint function and mobility and maintains gastrointestinal health.

The results of the clinical trial favor usage for other pathologies and will increase its presence in the international marketplace.

The derivation of PPG and Abexol from sugar cane wax minimizes adverse side effects.

Advertisement. Scroll to continue reading.

Recent Posts

WestJet CEO Meets with Cuban President Amid Hopes for Expansion of Passenger Flights to Havana

WestJet CEO Alexis von Hoensbroech met Wednesday with Cuban President Miguel Díaz-Canel in Havana, a high-level meeting…

1 week ago

Cuba Expands Solar Parks as Energy Deficits Persist

Cuba is ramping up efforts to address energy shortages through the expansion of photovoltaic solar…

2 weeks ago

Cuban Pianist Marcos Madrigal Awarded French Order of Arts and Letters

Renowned Cuban pianist Marcos Madrigal has been named Chevalier de l’Ordre des Arts et des Lettres by…

1 month ago

Russia to Provide Funding of $1 Billion for Investment Projects in Cuba

Russia will provide funding of $1 billion dollars for investment projects in Cuba, according to…

2 months ago

Cuba and China Confirm Strong Bilateral Ties at BRICS Meeting in Brazil

Cuba’s Foreign Affairs Minister Bruno Rodríguez Parrilla met with China's Foreign Minister, Wang Yi, on…

2 months ago

FitCuba 2025 International Tourism Fair Opens in Havana

Yesterday saw the opening of Cuba’s International Tourism Fair (FITCuba 2025) in Havana. The event,…

2 months ago